Justin Floyd
SWOG Cancer Research Network
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Justin Floyd as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:14 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT03418961 · S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicitySWOG Cancer Research Network · recruiting · Cardiotoxicity, HER2/Neu Positive, Metastatic Malignant Neoplasm in the Brain · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- SWOG NCORP Research BaseUG1CA189974 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI CHARLES D. BLANKE, DAWN HERSHMAN, Catherine M. Tangen · fiscal years 2014 to 2026Named on NCT03418961
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 10:14 UTC. The ranking covers the 200 most relevant of 2 PubMed records, and a shared surname and initials can bring in a namesake. All 2 on PubMed
- Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial.Nat Commun · 202448 citationsRCR 5.0
- Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904).BMC Med Inform Decis Mak · 20242 citationsRCR 0.2